Creating Biomedical Technologies to Improve Health


Molecular Imaging

This program supports development, optimization, and application of targeting imaging agents, imaging methods and related software/hardware for the detection of normal biological and pathophysiological processes in living subjects at the cellular and molecular levels. Imaging agents may include surface modified, molecular targeting or bioreactive nanoparticles, radionucleate-labeled agents, theranostic agents, and high sensitivity/specificity molecular imaging approaches, etc.  The goal of this program is to generate robust molecular imaging agents and platforms applicable to basic, preclinical and clinical research across all disease areas for better understanding of disease progression and therapeutic developments.